Trademark: 88799212
Status Date
Tuesday, August 25, 2020
Registration Number
6136258
Registration Date
Tuesday, August 25, 2020
Filing Date
Saturday, February 15, 2020
Published for Opposition
Tuesday, June 9, 2020
5 Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
Color is not claimed as a feature of the mark.
The mark consists of a stylized representation of the DNA molecule, between the upper strands of which is a roughly triangular shape.
Aug 25, 2020
Registered-Principal Register
Jun 14, 2020
Teas Change Of Correspondence Received
Jun 14, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 14, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
May 7, 2020
Approved For Pub - Principal Register
May 6, 2020
Assigned To Examiner
Feb 22, 2020
Notice Of Design Search Code E-Mailed
Feb 21, 2020
New Application Office Supplied Data Entered In Tram
Feb 19, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
